Is Thymosin Alpha-1 Legal in Kentucky?
HealthRX.com
No US approval, and Kentucky status is not confirmed here
Key numbers
- 1.6 mgDose of the finished Zadaxin injection sold outside the United StatesSource: fda.gov, as cited Nov 8, 2026
- 4 yes to 17 noFDA advisory committee vote against adding the peptide to the compounding bulks listSource: fda.gov, as cited Nov 8, 2026
- category 3FDA outsourcing facility category for the peptide, nominated without adequate supportSource: fda.gov, as cited Nov 8, 2026
- category 2Former FDA safety category for the peptide, left after nominators withdrewSource: fda.gov, as cited Nov 8, 2026
At a glance
- FDA approval / None; no US application exists [1]
- Approved elsewhere / Italy, India and Hong Kong, per FDA [1]
- FDA interim categories, state-licensed pharmacies / In none of the three; the category 1 policy does not apply [2]
- FDA pharmacy bulks list / FDA proposed not adding it; advisory committee voted 4 yes, 17 no [3]
- FDA outsourcing facility list / Category 3, 'nominated without adequate support' [5]
- HHS peptide draft policy / Not one of the six peptides covered [6]
Is it approved in the United States?
No. Thymosin alpha-1 (thymalfasin) is a 28-amino-acid peptide, and a Drugs@FDA search found no US application for it [1]. It holds four US orphan drug designations, but orphan designation is a separate process and is not an approval [1].
It is approved as a medicine in some other countries. FDA lists Italy, where Zadaxin is authorized as an adjuvant to influenza vaccination in immunocompromised people; India, for chronic hepatitis B in adults 18 or older with compensated liver disease and virus replication; and Hong Kong [1]. The European Medicines Agency holds only an orphan designation for hepatocellular carcinoma, which is not a marketing approval [1]. Zadaxin is the brand of the finished 1.6 mg injection sold outside the United States and is not interchangeable with bulk peptide powder [1]. No US-approved dose exists [1].
Can a Kentucky pharmacy compound it from bulk powder?
Federal rules let a state-licensed pharmacy use a bulk substance only if a USP or NF monograph exists for it, if it is a component of an FDA-approved drug, or if it appears on FDA's list of bulk substances that may be used in compounding [7]. Thymosin alpha-1 is not FDA-approved and is in none of FDA's three interim categories for state-licensed pharmacies, so FDA's category 1 policy does not cover it [1][2][7].
FDA has also proposed that thymosin alpha-1 not be added to the compounding bulks list. On December 4, 2024 its Pharmacy Compounding Advisory Committee voted 4 yes and 17 no, with no abstentions, on both the free base and the acetate; members who voted no cited no compelling evidence of clinical effectiveness and safety [3]. The peptide is also not one of the six in HHS's October 2026 draft enforcement-discretion policy (BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500) [6].
For outsourcing facilities, FDA places thymosin alpha-1 in category 3, meaning it was nominated without adequate support [5].
What FDA's safety findings say
FDA lists thymosin alpha-1 in its 'nominated but withdrawn' table; it had been in category 2 (significant safety risks) and came off because the nominators withdrew [8]. FDA's stated concerns remain posted: significant risk of immunogenicity for certain routes of administration, peptide-impurity and characterization problems, and safety information 'inadequate for the agency to sufficiently understand the extent of any safety issues' [8].
What this means in Kentucky
The Kentucky Board of Pharmacy regulates pharmacy practice in the Commonwealth [4]. FDA's lists above are federal, and none of the material here names a Kentucky statute, regulation or board action on thymosin alpha-1, so a Kentucky-specific permission or restriction is not confirmed on this page. The federal position stands on its own: there is no FDA-approved thymosin alpha-1 product [1].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
Questions worth asking
Frequently asked questions
Is thymosin alpha-1 legal in Kentucky?
Can a Kentucky compounding pharmacy make thymosin alpha-1?
Is thymosin alpha-1 approved in other countries?
Why did the FDA advisory committee vote against thymosin alpha-1?
Is thymosin alpha-1 part of the October 2026 HHS peptide policy?
References
Show all 8 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Welcome - PHARMACY.
- U.S. Food and Drug Administration.
- Official web page.
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.